Inhibitors of hepatitis c virus
AssigneePresidio Pharmaceuticals, Inc.
InventorsMin Zhong, Leping Li
Life of this patent
Estimating the term…
Abstract
A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.
Claims29
A compound according to structural Formula XIV:
- wherein:
- R′1 is selected from
- H, —F, —Cl, —Br, and —I;
- R′2 is selected from —OH, —OCH3,
- X′ is selected from ═O, ═N—OH, ═N—O(CH2CH2O)0-8CH3, and ═N—O(CH2)1-23CH3, and
- R′3 is selected from —CH3 and —OCH3.
A compound according to structural Formula XIV-a:
- wherein:
- R′1 is selected from
- —H, —F, —Cl, —Br, and —I;
- R′2 is selected from —OH, —OCH3,
- R′3 is selected from —CH3 and —OCH3.
A compound according to structural Formula XIV-a:
- wherein:
- R′1 is selected from para-
- and para-F,
- R′2 is selected from
- and
- R′3 is selected from —CH3 and —OCH3.
A compound having the structure:
- where R′1 is either para-
- or para-F,
- is a residue of an amino acid according to the structure:
- where Raa is the side-chain of the amino acid, and
- R′3 is selected from —CH3 and —OCH3.
A compound selected from the group consisting of B243, B244, B245, B246, B247, B248, B249, B250, B251, B252, B253, B254, B255, B256, B257, B258, B259, B260, B261, B262, B263, B264, B265, B266, B267, B268, B269, B270, B271, B272, B273, B274, B275, B276, B277, B278, B279, B280, B281, B282, B283, B284, B285, B286, B287, B288, B289, D8, D9, D10, D11, D12, D13, D14, D26, D27, D37, D38, D42, D43, D44, D45, D46, D47, D48, D49, D50, D51, D52, D53, D54, D55, D56, D57, D71, D72, D75, D76, D77, D78, D79. D80, D81, D82, D83, D84, D85, D86, D87, D88, D89, and D90.
A compound having the structure:
Dependencies are inferred from the claim text.